195 related articles for article (PubMed ID: 330945)
21. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
[TBL] [Abstract][Full Text] [Related]
22. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
23. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
24. DDS-resistant leprosy.
Neelan PN; Reddy BN
Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):115-8. PubMed ID: 3889186
[No Abstract] [Full Text] [Related]
25. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
[No Abstract] [Full Text] [Related]
26. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
Almeida JG; Chacko CJ; Christian M
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
[TBL] [Abstract][Full Text] [Related]
27. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
28. Infectivity of secondary dapsone-resistant cases.
Jesudasan K; Pannikar V; Christian M
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):418-21. PubMed ID: 3047282
[TBL] [Abstract][Full Text] [Related]
29. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
Ylitalo P; Hinkka H
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
[TBL] [Abstract][Full Text] [Related]
30. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
[TBL] [Abstract][Full Text] [Related]
31. Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
Peters JH; Gordon GR; Levy L; Strokan MA; Jacobson RR; Enna CD; Kirchheimer WF
Am J Trop Med Hyg; 1974 Mar; 23(2):222-30. PubMed ID: 4817667
[No Abstract] [Full Text] [Related]
32. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
[No Abstract] [Full Text] [Related]
33. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
[No Abstract] [Full Text] [Related]
35. The clinical diagnosis of dapsone resistant leprosy.
Taylor PM
Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897
[TBL] [Abstract][Full Text] [Related]
36. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
Waters MF; Pearson JM; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
[No Abstract] [Full Text] [Related]
37. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
38. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
39. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
[TBL] [Abstract][Full Text] [Related]
40. Secondary dapsone-resistant leprosy in Shanghai Municipality.
Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
